Palatin Technologies, Inc. (PTN)
USD 0.75
(-9.64%)
USD 0.75
(-9.64%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -29.03 Million USD | 10.56% |
| 2023 | -32.45 Million USD | 11.29% |
| 2022 | -35.68 Million USD | -19.57% |
| 2021 | -33.38 Million USD | -29.62% |
| 2020 | -22.04 Million USD | -165.94% |
| 2019 | 35.8 Million USD | 37.79% |
| 2018 | 25.98 Million USD | 345.83% |
| 2017 | -10.51 Million USD | 78.52% |
| 2016 | -49.2 Million USD | -186.61% |
| 2015 | -17.41 Million USD | -8.75% |
| 2014 | -15.65 Million USD | -2.03% |
| 2013 | -22.49 Million USD | 13.25% |
| 2012 | -17.36 Million USD | -42.51% |
| 2011 | -12.3 Million USD | -617.21% |
| 2010 | -1.5 Million USD | 70.61% |
| 2009 | -5.15 Million USD | 61.04% |
| 2008 | -14.2 Million USD | 46.25% |
| 2007 | -27.02 Million USD | 2.86% |
| 2006 | -28.33 Million USD | -103.58% |
| 2005 | -14.33 Million USD | 45.39% |
| 2004 | -26.08 Million USD | -24.5% |
| 2003 | -20.45 Million USD | -32.76% |
| 2002 | -15.68 Million USD | -41.5% |
| 2001 | -11.05 Million USD | -27.66% |
| 2000 | -8.29 Million USD | 17.05% |
| 1999 | -10.59 Million USD | -24.71% |
| 1998 | -8.16 Million USD | -70.0% |
| 1997 | -4.7 Million USD | -16.55% |
| 1996 | -4.29 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -6.02 Million USD | 45.9% |
| 2024 Q4 | -8.16 Million USD | 1.18% |
| 2024 Q3 | -9.02 Million USD | -7.7% |
| 2024 Q2 | -6.48 Million USD | -34.56% |
| 2023 FY | - USD | 11.29% |
| 2023 Q3 | -7.22 Million USD | -10.38% |
| 2023 Q2 | -6.54 Million USD | 24.72% |
| 2023 Q1 | -8.69 Million USD | 33.65% |
| 2023 Q4 | -9.7 Million USD | -34.42% |
| 2022 FY | - USD | -19.57% |
| 2022 Q1 | -7.2 Million USD | 22.5% |
| 2022 Q2 | -8.42 Million USD | -16.94% |
| 2022 Q3 | -7.77 Million USD | 7.68% |
| 2022 Q4 | -13.1 Million USD | -68.47% |
| 2021 Q1 | -5.55 Million USD | 24.82% |
| 2021 FY | - USD | -29.62% |
| 2021 Q2 | -9.23 Million USD | -66.3% |
| 2021 Q3 | -6.48 Million USD | 29.8% |
| 2021 Q4 | -9.29 Million USD | -43.3% |
| 2020 Q3 | -5.69 Million USD | -1.03% |
| 2020 Q1 | -4.84 Million USD | -109.28% |
| 2020 Q2 | -5.64 Million USD | -16.45% |
| 2020 Q4 | -7.38 Million USD | -29.67% |
| 2020 FY | - USD | -165.94% |
| 2019 Q2 | -5.03 Million USD | 10.52% |
| 2019 Q1 | -5.62 Million USD | -145.49% |
| 2019 Q3 | -5.74 Million USD | -14.11% |
| 2019 Q4 | 52.2 Million USD | 1008.3% |
| 2019 FY | - USD | 37.79% |
| 2018 Q2 | 3.03 Million USD | -73.13% |
| 2018 Q1 | 11.3 Million USD | -21.18% |
| 2018 FY | - USD | 345.83% |
| 2018 Q3 | -417.25 Thousand USD | -113.74% |
| 2018 Q4 | 12.37 Million USD | 3065.59% |
| 2017 Q3 | -2.99 Million USD | 68.22% |
| 2017 Q4 | 14.33 Million USD | 578.15% |
| 2017 FY | - USD | 78.52% |
| 2017 Q2 | -9.43 Million USD | 24.04% |
| 2017 Q1 | -12.42 Million USD | 2.33% |
| 2016 Q3 | -12.05 Million USD | 4.35% |
| 2016 Q4 | -12.71 Million USD | -5.45% |
| 2016 FY | - USD | -186.61% |
| 2016 Q2 | -12.6 Million USD | -7.11% |
| 2016 Q1 | -11.77 Million USD | -0.19% |
| 2015 Q4 | -11.74 Million USD | -35.19% |
| 2015 Q2 | 2.35 Million USD | 155.05% |
| 2015 FY | - USD | -8.75% |
| 2015 Q3 | -8.69 Million USD | -469.79% |
| 2015 Q1 | 921.48 Thousand USD | 121.33% |
| 2014 Q3 | -3.33 Million USD | 6.84% |
| 2014 Q2 | -3.58 Million USD | 19.8% |
| 2014 Q1 | -4.46 Million USD | 4.8% |
| 2014 FY | - USD | -2.03% |
| 2014 Q4 | -4.32 Million USD | -29.52% |
| 2013 Q3 | -3.99 Million USD | -17.07% |
| 2013 Q4 | -4.69 Million USD | -17.38% |
| 2013 FY | - USD | 13.25% |
| 2013 Q1 | -3.37 Million USD | 38.43% |
| 2013 Q2 | -3.41 Million USD | -1.2% |
| 2012 FY | - USD | -42.51% |
| 2012 Q4 | -5.47 Million USD | 5.39% |
| 2012 Q3 | -5.79 Million USD | -67.59% |
| 2012 Q2 | -3.45 Million USD | -10.51% |
| 2012 Q1 | -3.12 Million USD | 27.52% |
| 2011 FY | - USD | -617.21% |
| 2011 Q4 | -4.31 Million USD | -83.99% |
| 2011 Q3 | -2.34 Million USD | -52.51% |
| 2011 Q2 | -1.53 Million USD | 64.58% |
| 2011 Q1 | -4.33 Million USD | -9.77% |
| 2010 Q4 | -3.95 Million USD | -128.13% |
| 2010 Q2 | 3.79 Million USD | 16314.79% |
| 2010 Q1 | 23.09 Thousand USD | -82.66% |
| 2010 FY | - USD | 70.61% |
| 2010 Q3 | -1.73 Million USD | -145.72% |
| 2009 FY | - USD | 61.04% |
| 2009 Q2 | -2.44 Million USD | 40.52% |
| 2009 Q3 | 398.45 Thousand USD | 116.31% |
| 2009 Q4 | 133.12 Thousand USD | -66.59% |
| 2009 Q1 | -4.1 Million USD | 17.52% |
| 2008 FY | - USD | 46.25% |
| 2008 Q1 | -681.05 Thousand USD | 88.87% |
| 2008 Q2 | -5.34 Million USD | -684.3% |
| 2008 Q3 | -5.14 Million USD | 3.69% |
| 2008 Q4 | -4.98 Million USD | 3.18% |
| 2007 Q1 | -8.73 Million USD | -10.43% |
| 2007 FY | - USD | 2.86% |
| 2007 Q3 | -7.05 Million USD | 3.95% |
| 2007 Q2 | -7.34 Million USD | 15.87% |
| 2007 Q4 | -6.12 Million USD | 13.25% |
| 2006 FY | - USD | -103.58% |
| 2006 Q2 | -8.7 Million USD | -29.79% |
| 2006 Q4 | -7.9 Million USD | -6.69% |
| 2006 Q3 | -7.41 Million USD | 14.91% |
| 2006 Q1 | -6.71 Million USD | -37.87% |
| 2005 Q1 | -3.35 Million USD | 50.28% |
| 2005 Q2 | -3.03 Million USD | 9.6% |
| 2005 Q3 | -3.77 Million USD | -24.5% |
| 2005 FY | - USD | 45.39% |
| 2005 Q4 | -4.86 Million USD | -28.87% |
| 2004 FY | - USD | -24.5% |
| 2004 Q2 | -4.75 Million USD | 29.34% |
| 2004 Q3 | -7.94 Million USD | -67.13% |
| 2004 Q4 | -6.74 Million USD | 15.02% |
| 2004 Q1 | -6.72 Million USD | -4.9% |
| 2003 Q2 | -4.5 Million USD | -7.54% |
| 2003 Q4 | -6.41 Million USD | -15.48% |
| 2003 Q3 | -5.55 Million USD | -23.24% |
| 2003 Q1 | -3.99 Million USD | 12.79% |
| 2003 FY | - USD | -32.76% |
| 2002 Q3 | -3.85 Million USD | 3.16% |
| 2002 FY | - USD | -41.5% |
| 2002 Q1 | -2.67 Million USD | 52.43% |
| 2002 Q2 | -4.01 Million USD | -126.08% |
| 2002 Q4 | -4.8 Million USD | -24.69% |
| 2001 FY | - USD | -27.66% |
| 2001 Q4 | -3.69 Million USD | -31.06% |
| 2001 Q3 | -2.82 Million USD | -25.62% |
| 2001 Q2 | -2.24 Million USD | -0.39% |
| 2001 Q1 | -2.23 Million USD | 31.97% |
| 2000 Q4 | -3.28 Million USD | -79.48% |
| 2000 Q2 | -1.8 Million USD | -38.46% |
| 2000 Q3 | -1.83 Million USD | -1.82% |
| 2000 Q1 | -1.3 Million USD | 58.06% |
| 2000 FY | - USD | 17.05% |
| 1999 Q4 | -3.1 Million USD | -6.9% |
| 1999 Q1 | -2.6 Million USD | -3.85% |
| 1999 Q2 | -1.8 Million USD | 33.33% |
| 1999 FY | - USD | -24.71% |
| 1999 Q3 | -2.94 Million USD | -61.11% |
| 1998 Q1 | -1.8 Million USD | -31.94% |
| 1998 FY | - USD | -70.0% |
| 1998 Q4 | -2.5 Million USD | -85.71% |
| 1998 Q2 | -2.3 Million USD | -21.05% |
| 1998 Q3 | -1.3 Million USD | 39.13% |
| 1997 Q4 | -1.44 Million USD | -8.27% |
| 1997 Q1 | -1.29 Million USD | 0.0% |
| 1997 FY | - USD | -16.55% |
| 1997 Q3 | -1.33 Million USD | -13.68% |
| 1997 Q2 | -1.17 Million USD | 9.3% |
| 1996 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -31.67 Million USD | 8.356% |
| Ampio Pharmaceuticals, Inc. | - USD | Infinity% |
| Armata Pharmaceuticals, Inc. | -39.91 Million USD | 27.273% |
| Actinium Pharmaceuticals, Inc. | -51.13 Million USD | 43.221% |
| Azitra, Inc. | -10.67 Million USD | -172.0% |
| Can-Fite BioPharma Ltd. | -8.18 Million USD | -254.904% |
| Chromocell Therapeutics Corporation | -6.86 Million USD | -323.054% |
| Calidi Biotherapeutics, Inc. | -28.6 Million USD | -1.507% |
| CEL-SCI Corporation | -27.56 Million USD | -5.336% |
| iBio, Inc. | -14.02 Million USD | -107.055% |
| Lineage Cell Therapeutics, Inc. | -24.73 Million USD | -17.378% |
| MAIA Biotechnology, Inc. | -20.18 Million USD | -43.844% |
| Matinas BioPharma Holdings, Inc. | -22.82 Million USD | -27.19% |
| Navidea Biopharmaceuticals, Inc. | -13.87 Million USD | -109.232% |
| NovaBay Pharmaceuticals, Inc. | -4.8 Million USD | -504.815% |
| NanoViricides, Inc. | -7.75 Million USD | -274.253% |
| Oragenics, Inc. | -20.87 Million USD | -39.055% |
| BiomX Inc. | -22.81 Million USD | -27.246% |
| BiomX Inc. | -22.81 Million USD | -27.246% |
| Protalix BioTherapeutics, Inc. | 11.65 Million USD | 349.173% |
| Scorpius Holdings, Inc. | -35.08 Million USD | 17.249% |